ART with long-term effects without immunosuppression

Published Date: 02 Mar 2023

The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.

Read Full News

Latest News

Exclusive-US Upends Global Supply Program for Malaria and HIV Amid Warnings of Gaps

The U.S. is upending the way it delivers medical supplies for diseases such as HIV and malaria to lower-income countries, according to seven sources and an internal email,...

African Ancestry Linked to Fewer TB Adverse Events

A 10% rise in African ancestry lowered odds of moderate TB drug reactions, while a 10% increase in European ancestry raised them — implications for surveillance.

Cervical Cancer Screening Update: Why Less Is More

Cervical cancer screening has evolved. Dr Neil Skolnik delivers an update on why we now wait until age 25 to start and how self-testing is changing the pelvic exam landscape.

Exclusive-Pfizer, BioNTech Halt US COVID Vaccine Study After Recruitment Struggles

Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too...

Low CD4 Count Tied to Cervical Cancer Risk in HIV Infection

A lower CD4 count is associated with a higher risk for cervical carcinoma in situ and cervical cancer in women with HIV infection.

Does HIV Status Affect Long COVID Manifestations?

Patients with HIV infection are at a higher risk of developing long COVID manifestations than those without HIV infection.

Todays Updates

Why Encouragement May Not Improve Motivation in Depression

A meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets for improving motivation and functional outcomes.

Assisted Dying Under Scrutiny From Medscape's Readers

Comments on a Medscape feature push past ideology to ask what evidence, oversight, and safeguards should be available for patients who choose assisted death.

Chemotherapy Boosts Survival for Older Patients With TNBC

Patients aged 70 years or older stand to benefit from adjuvant chemotherapy for triple-negative breast cancer, but the majority do not receive it.

Venetoclax Combo Shows Promise in Younger Patients With AML

Researchers conducted a systematic review and meta-analysis for studies of acute myeloid leukemia patients with a median age less than 70 treated with HMA plus venetoclax.

Radioligand Therapy Set to Transform Oncology Care

Nearly 400 trials and Belgium’s isotope hub signal rapid clinical diversification for radioligand therapy — but policy, funding, and system readiness must follow.

Todays Updates

Why Encouragement May Not Improve Motivation in Depression

A meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets for improving motivation and functional outcomes.

Assisted Dying Under Scrutiny From Medscape's Readers

Comments on a Medscape feature push past ideology to ask what evidence, oversight, and safeguards should be available for patients who choose assisted death.

Chemotherapy Boosts Survival for Older Patients With TNBC

Patients aged 70 years or older stand to benefit from adjuvant chemotherapy for triple-negative breast cancer, but the majority do not receive it.

Venetoclax Combo Shows Promise in Younger Patients With AML

Researchers conducted a systematic review and meta-analysis for studies of acute myeloid leukemia patients with a median age less than 70 treated with HMA plus venetoclax.

Radioligand Therapy Set to Transform Oncology Care

Nearly 400 trials and Belgium’s isotope hub signal rapid clinical diversification for radioligand therapy — but policy, funding, and system readiness must follow.

Latest News

The U.S. is upending the way it delivers medical supplies for diseases such as HIV and malaria to lower-income countries, according to seven sources and an internal email,...

A 10% rise in African ancestry lowered odds of moderate TB drug reactions, while a 10% increase in European ancestry raised them — implications for surveillance.

Cervical cancer screening has evolved. Dr Neil Skolnik delivers an update on why we now wait until age 25 to start and how self-testing is changing the pelvic exam landscape.

Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 vaccine in healthy adults aged 50 to 64, saying enrollment in the trials had been too...

A lower CD4 count is associated with a higher risk for cervical carcinoma in situ and cervical cancer in women with HIV infection.

Patients with HIV infection are at a higher risk of developing long COVID manifestations than those without HIV infection.

News All Time

Around 4.9 Million Children Under Five Died in 2024, Says UN

About 4.9 million children died before reaching their fifth birthday in 2024, according to new United Nations estimates, a sign progress ⁠to reduce child mortality rates was...

UK Races to Contain Meningitis Outbreak in Kent After Two Deaths

Britain will roll out meningitis vaccines to students at a university in southeast England after an "unprecedented" outbreak of the disease killed two people while the...

Treating Gonorrhea Orally: Access vs Resistance

Zoliflodacin and gepotidacin make oral therapy viable again for urogenital gonorrhea, yet lower pharyngeal efficacy and weak resistance surveillance mean clinicians must adopt cautious, targeted use.

Starting HIV PrEP in the Second Trimester Appears Safe

In pregnant women testing negative for HIV, second-trimester preexposure prophylaxis with the dapivirine vaginal ring or oral tenofovir disoproxil fumarate-emtricitabine is safe.

Drop in HIV/HCV Coinfections After Nationwide HCV Program

Following Iceland’s national hepatitis C elimination program, a substantial reduction was observed in the number of HIV/hepatitis C virus coinfections from 2016 to 2020.

Doctors Warn of a Deadly Complication From Measles Outbreaks

Measles causes complications — ranging from diarrhea to death — in 3 in 10 infected people, according to the Infectious Diseases Society of America.

Physician Groups Applaud Decision to Pause Vaccine Overhaul

A federal judge found that HHS acted illegally in appointing vaccine advisers and unilaterally changing the immunization schedule.

FDA Approves Expanded Age Indication for RSV Vaccine

The FDA has approved expanded use of Arexvy, an RSV vaccine, for those aged 18-49 at increased LRTD risk.

Same-Day ART Matches Delayed ART for HIV With TB Symptoms

Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until tuberculosis test results are available, with similar viral suppression.

US Insurers and Hospitals Turn to New AI for Age-old Battle Over Charges Vs Payments

Artificial intelligence is being deployed on both sides of the tug-of-war between U.S. healthcare systems that want to be paid more for medical procedures and insurers who...

Viatris Settles lawsuit Over Use Of Woman's 'immortal' Cells to Power Drug Research

Generic drugmaker Viatris has settled a lawsuit brought by the family of Henrietta Lacks, a Maryland woman whose ⁠tissue samples were used without her permission to develop...

RSV Hospitalization Burden Rises With Age and Comorbidities

Respiratory syncytial virus is associated with a greater burden of hospitalizations in older adults and in those with congestive heart failure or chronic obstructive pulmonary disease.

US Vaccine Advisers Drop Plan to Question MRNA COVID Shots, WaPo Reports

A key U.S. federal vaccine advisory panel has dropped a push against COVID mRNA vaccines, ⁠the Washington Post reported on Wednesday, citing two people familiar with the...

South Carolina Reports One Additional Measles Case, Total Cases Rise to 991

Measles cases in South Carolina rose to 991 on Friday, state health data ⁠showed, an increase of one case since Tuesday as the nation's largest outbreak in ⁠decades shows...

No Link Between HPV Vaccination and Infertility

A Cochrane review of 225 studies covering 132 million vaccinated people found, with high certainty, that HPV vaccination does not cause fertility problems, refuting a common myth.

mRNA RSV Vaccine Safe in Transplant Recipients

mRNA-1345 vaccine is safe and well tolerated and elicits measurable antibody and cellular immune responses in recipients with solid organ transplant.

Recommended News For You

High levels of traumatic stress found in caregivers of adult cancer patients

Journal Club: A well-accepted and safe method for soft tissue sarcoma biopsy.

Additional Proof of the Different Cognitive Effects of ARSIs for Prostate Cancer.

Alcohol Causes Cancer. We Should Be Drinking Less.

A new blood test greatly increases the ability to detect cancer.

Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control

PFS in Multiple Myeloma Is Improved by Daratumumab Added to Standard Therapy.

Recommended Articles For You

AI in Cancer Care: Transforming Research & Treatment with Deep Learning Technologies 

New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results 

Unlocking the Mysteries of ICD 10 Code Normocytic Anemia 

The Importance of Early Detection in Angiosarcoma: A Story of Survival  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

ALK-positive lung cancer trial results show unprecedented progression-free survival.

2.

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

3.

Research finds low uptake of supportive care at the end-of-life for patients with advanced cancer

4.

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

5.

Resection for Early Liver Cancer Tied to Improved Survival.

1.

The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough

2.

Survival Rate Dynamics in Hematologic and Solid Malignancies

3.

Multimodal Data Fusion with Deep Neural Networks - Revolutionizing Oncology with Precision Cancer Diagnosis 2025

4.

The Capmist DM: A Revolutionary Way to Combat Dry Mouth

5.

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

4.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions

5.

Newer Immunotherapies for Myeloma- A Comprehensive Overview


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot